Lung Cancer

Latest Lung Cancer News

Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations

Osimertinib (Tagrisso) demonstrated promising clinical activity as first-line treatment for patients with

Derick Alison Derick Alison

FDA OKs New Option for Advanced ROS1-Positive Lung Cancer

The FDA approved repotrectinib (Augtyro) -- an oral tyrosine kinase inhibitor (TKI)

Derick Alison Derick Alison

Pembrolizumab Wins FDA Approval in Operable Lung Cancer

The FDA approved pembrolizumab (Keytruda) on Monday in combination with platinum-based chemotherapy

Derick Alison Derick Alison

New Lung Cancer Cases Are Higher in Younger Women vs Men

Updated population-based data showed that while lung cancer incidence rates are continuing

Derick Alison Derick Alison

Combination Therapy Wins FDA Approval for BRAF-Mutated NSCLC

The FDA approved encorafenib (Braftovi) plus binimetinib (Mektovi) for BRAF V600E-mutated metastatic

Derick Alison Derick Alison

Sotorasib’s Confirmatory Data in NSCLC Unreliable, Says FDA Panel

An FDA advisory committee on Thursday said the confirmatory trial data for

Derick Alison Derick Alison

Drugmaker Plans to Pull Lung Cancer Therapy From the Market

Mobocertinib (Exkivity) will be withdrawn from the U.S. market after a failed

Derick Alison Derick Alison

FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLC

Ahead of a meeting of the Oncologic Drugs Advisory Committee on Thursday,

Derick Alison Derick Alison

Anti-TIGIT Plus Immunotherapy ‘Promising’ in NSCLC, Esophageal Cancer

Combination treatment with an investigational anti-TIGIT drug plus a PD-L1 inhibitor was

Derick Alison Derick Alison